Sentence examples for progressing phase from inspiring English sources

Our results indicate that HSP 60 was consistently higher in CTVT cells in regressing phase than those in progressing phase.

Specific cytokines/chemokines/neurotrophic factor messenger RNA levels were assessed at disease onset (11 weeks), the stable disease phase (14 and 16 weeks), the point at which disease progression rapidly accelerates (18 weeks), the rapidly progressing phase (20 weeks), and end stage disease; age-matched wild-type mice served as controls.

Analyses were performed at disease onset (11 weeks), the stable disease phase (14 and 16 weeks), the point at which disease progression begins to rapidly accelerate (18 weeks), the rapidly progressing phase (20 weeks) and end stage disease (∼23 weeks; Fig. 1A and Supplementary Fig. 1A).

But the problem with modernization theory was always a tendency to concentrate most of its attention on the steadily progressing phases of history, as determined by the predictable workings of sociology or economics or psychology — and to relegate the free play of unpredictable ideas and ideologies to the margins of world events.

However, existing systems have limitations in that they only support a one-time evaluation of CO2 emissions during the early planning or progress phase and cannot effectively provide feedback on evaluation results.

Nevertheless, also in these more progressed phases, EPO superiority was visible when analysing more subtle readouts of cognitive performance, for example, stability and task adaptation.

Both of these agents are progressing in phase III trials.

The second most frequent reason for compounds not progressing beyond Phase I trials is that the agent was superseded by an improved analogue or derivative.

Other reasons for compounds not progressing beyond Phase I trials included poor pharmacokinetics or potency and problems with the supply of the clinical material.

Phase III: Permanent Agreement in 2005 THE SPONSORS -- evaluate progress from Phase II; when ready, they will convene another international conference, aiming for 2004.

Elesclomol had progressed to Phase 2 for soft-tissue sarcomas and for lung cancer, and had come up short in both cases.